정량 흡입기 시장 - 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2032년)

The global metered dose inhalers market is on track for notable growth, with a projected compound annual growth rate (CAGR) of 4.9%. It is anticipated to grow from USD 31.03 billion in 2025 to USD 43.35 billion by 2032. MDIs play a pivotal role in respiratory drug delivery, ensuring precise and controlled administration of medication for conditions like asthma and chronic obstructive pulmonary disease (COPD).

Metered dose inhalers are compact, handheld devices designed to effectively deliver aerosolized medication. Their portability, ease of use, and precision make them essential tools in managing respiratory disorders. Increasing cases of respiratory diseases worldwide, along with advancements in inhaler technology, have significantly driven the demand for MDIs.

Key Market Drivers

• 1.Technological Advancements: Innovation in inhaler design and formulation has been a major growth factor. Collaborations between pharmaceutical firms and research institutions have paved the way for intelligent inhalers integrated with digital technology and sensors, improving patient adherence and enabling personalized treatments.
• 2.Rising Respiratory Disease Burden: Growing incidences of asthma, COPD, and other respiratory disorders are driving the demand for effective inhalation therapies.
• 3.Patient-Centric Features: The inclusion of user-friendly designs and digital solutions in MDIs has enhanced patient engagement and adherence to prescribed treatments.

Business Opportunities

The rise of connected devices and digital health platforms presents significant opportunities in the global metered dose inhalers market. Smart inhalers embedded with sensors provide real-time data on medication usage, enabling healthcare providers to tailor treatment strategies and enhance patient outcomes. These devices also empower patients through feedback, reminders, and educational tools available via mobile apps.

Market Restraints

• 1.Environmental Concerns: Conventional MDIs depend on hydrofluoroalkane (HFA) propellants, which have high global warming potential. Regulatory efforts are urging manufacturers to transition to more eco-friendly alternatives.
• 2.Regulatory Challenges: Complex and evolving regulatory requirements for new inhaler technologies pose significant hurdles for manufacturers, necessitating rigorous validation and compliance efforts.

Regional Analysis

• 1.Asia Pacific: The region is expected to lead the market, driven by a large population base with a high prevalence of respiratory conditions. Countries like China and India are seeing increased adoption of advanced respiratory therapies due to better healthcare infrastructure and economic growth.
• 2.Latin America: The fastest-growing region, Latin America's market expansion is propelled by rising awareness of respiratory health, improved healthcare facilities, and access to advanced inhaler technologies.
• 3.North America and Europe: These regions remain major markets due to high healthcare spending and advanced infrastructure, although the Asia Pacific region is emerging as a critical growth area for industry players.

Competitive Analysis

The metered dose inhalers market is highly competitive, with leading players focusing on innovation, partnerships, and global expansion to strengthen their market presence. Key companies include:

• Cipla Inc.
• Presspart Manufacturing Ltd.
• Midascare Pharmaceuticals Pvt. Ltd.
• Beximco Pharma Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• 3M Pharmaceuticals Pty Ltd.
• Biocare Manufacturing Sdn Bhd.
• Anomatic Innovation & Design Center & Manufacturing
• Aristo Pharma Ltd.

Metered Dose Inhalers Market Segmentation

• By Type:
• Reliever Inhaler
• Long-acting Bronchodilator Inhaler
• By End Use:
• Homecare
• Hospitals
• Clinics
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Metered Dose Inhalers Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

• 3.1. Global Average Price Analysis, by Type, US$ Per Unit, 2019 - 2023
• 3.2. Prominent Factor Affecting Metered Dose Inhalers Prices
• 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Metered Dose Inhalers Market Outlook, 2019 - 2032

• 4.1. Global Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Reliever Inhaler
    • 4.1.1.2. Long-acting bronchodilators Inhaler
• 4.2. Global Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Homecare
    • 4.2.1.2. Hospitals
    • 4.2.1.3. Clinics
• 4.3. Global Metered Dose Inhalers Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. North America
    • 4.3.1.2. Europe
    • 4.3.1.3. Asia Pacific
    • 4.3.1.4. Latin America
    • 4.3.1.5. Middle East & Africa

5. North America Metered Dose Inhalers Market Outlook, 2019 - 2032

• 5.1. North America Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Reliever Inhaler
    • 5.1.1.2. Long-acting bronchodilators Inhaler
• 5.2. North America Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Homecare
    • 5.2.1.2. Hospitals
    • 5.2.1.3. Clinics
• 5.3. North America Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. U.S. Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.2. U.S. Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.3. Canada Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.4. Canada Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Metered Dose Inhalers Market Outlook, 2019 - 2032

• 6.1. Europe Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Reliever Inhaler
    • 6.1.1.2. Long-acting bronchodilators Inhaler
• 6.2. Europe Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Homecare
    • 6.2.1.2. Hospitals
    • 6.2.1.3. Clinics
• 6.3. Europe Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Germany Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.2. Germany Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.3. U.K. Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.4. U.K. Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.5. France Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.6. France Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.7. Italy Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.8. Italy Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.9. Turkey Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.10. Turkey Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.11. Russia Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.12. Russia Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.13. Rest of Europe Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.14. Rest of Europe Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Metered Dose Inhalers Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Reliever Inhaler
    • 7.1.1.2. Long-acting bronchodilators Inhaler
• 7.2. Asia Pacific Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Homecare
    • 7.2.1.2. Hospitals
    • 7.2.1.3. Clinics
• 7.3. Asia Pacific Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. China Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.2. China Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.3. Japan Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.4. Japan Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.5. South Korea Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.6. South Korea Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.7. South Korea Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.8. India Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.9. India Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.10. Southeast Asia Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.11. Southeast Asia Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.12. Rest of Asia Pacific Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.13. Rest of Asia Pacific Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Metered Dose Inhalers Market Outlook, 2019 - 2032

• 8.1. Latin America Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Reliever Inhaler
    • 8.1.1.2. Long-acting bronchodilators Inhaler
• 8.2. Latin America Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Homecare
    • 8.2.1.2. Hospitals
    • 8.2.1.3. Clinics
• 8.3. Latin America Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Brazil Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.2. Brazil Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.3. Mexico Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.4. Mexico Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.5. Argentina Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.6. Argentina Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.7. Rest of Latin America Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.8. Rest of Latin America Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Metered Dose Inhalers Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Reliever Inhaler
    • 9.1.1.2. Long-acting bronchodilators Inhaler
• 9.2. Middle East & Africa Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Homecare
    • 9.2.1.2. Hospitals
    • 9.2.1.3. Clinics
• 9.3. Middle East & Africa Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. GCC Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.2. GCC Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.3. South Africa Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.4. South Africa Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.5. Egypt Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.6. Egypt Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.7. Nigeria Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.8. Nigeria Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.9. Rest of Middle East & Africa Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.10. Rest of Middle East & Africa Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

• 10.1. Type vs End User Heatmap
• 10.2. Company Market Share Analysis, 2024
• 10.3. Competitive Dashboard
• 10.4. Company Profiles
  • 10.4.1. Cipla Inc.
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Product Portfolio
    • 10.4.1.3. Financial Overview
    • 10.4.1.4. Business Strategies and Development
  • 10.4.2. Presspart Manufacturing Ltd.
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Product Portfolio
    • 10.4.2.3. Financial Overview
    • 10.4.2.4. Business Strategies and Development
  • 10.4.3. Midascare Pharmaceuticals Pvt. Ltd.
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Product Portfolio
    • 10.4.3.3. Financial Overview
    • 10.4.3.4. Business Strategies and Development
  • 10.4.4. Beximco Pharma Ltd.
    • 10.4.4.1. Company Overview
    • 10.4.4.2. Product Portfolio
    • 10.4.4.3. Financial Overview
    • 10.4.4.4. Business Strategies and Development
  • 10.4.5. GlaxoSmithKline Pharmaceuticals Ltd.
    • 10.4.5.1. Company Overview
    • 10.4.5.2. Product Portfolio
    • 10.4.5.3. Financial Overview
    • 10.4.5.4. Business Strategies and Development
  • 10.4.6. 3M Pharmaceuticals Pty Ltd.
    • 10.4.6.1. Company Overview
    • 10.4.6.2. Product Portfolio
    • 10.4.6.3. Financial Overview
    • 10.4.6.4. Business Strategies and Development
  • 10.4.7. Biocare Manufacturing Sdn Bhd.
    • 10.4.7.1. Company Overview
    • 10.4.7.2. Product Portfolio
    • 10.4.7.3. Financial Overview
    • 10.4.7.4. Business Strategies and Development
  • 10.4.8. Anomatic Innovation & Design Center & Manufacturing
    • 10.4.8.1. Company Overview
    • 10.4.8.2. Product Portfolio
    • 10.4.8.3. Financial Overview
    • 10.4.8.4. Business Strategies and Development
  • 10.4.9. Aristo Pharma Ltd.
    • 10.4.9.1. Company Overview
    • 10.4.9.2. Product Portfolio
    • 10.4.9.3. Financial Overview
    • 10.4.9.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations